Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Supply of 10-Stage MOUDI-II Particle Sizer (Model 120R)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the procurement and delivery of a 10-stage MOUDI-II Particle Sizer, Model 120R, designed to measure airborne particles ranging from 0.05 to 18 micrometers. This equipment is intended to support inhalation research at the National Institute for Occupational Safety and Health (NIOSH) laboratory under the Centers for Disease Control and Prevention (CDC). The acquisition is managed by the CDC Office of Acquisition Services within the Department of Health and Human Services and is classified as a total small business set-aside under the Small Business Administration guidelines. The subcontract falls under the NAICS code 334516, which pertains to measuring and testing instrument manufacturing. The solicitation was posted on June 10, 2026, with a response deadline of June 18, 2026. The place of performance is specified as Morgantown. This contract is intended to enhance the CDC's capability to conduct detailed particle size analysis for research purposes, contributing to improved understanding and control of particulate exposure in occupational environments.

General Info

Procurement of 10-stage MOUDI-II Particle Sizer for NIOSH CDC inhalation research, small business set-aside.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Morgantown, WV, USA

Set-Aside

SBA

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Procurement and delivery of a 10-stage MOUDI-II Particle Sizer, Model 120R, for measuring particles from 0.05 to 18 µm to support inhalation research at CDC’s NIOSH laboratory.

Similar Contracts

NAICS: 334516
New
Federal
FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or EqualThe contract solicitation seeks quotations for supplying parts and components compatible with three Nova BioProfile FLEX 2 instruments owned by the FDA’s Center for Drug Evaluation and Research (CDER). The requirement includes parts for two main FLEX2 instruments and an additional external sampling module, each identified by specific serial numbers. The contractor must provide new, unused, and defect-free commercial parts or equivalent consumables that fully function with the instruments in their current configuration, without requiring modifications. Delivered items must maintain at least 75% to 80% of their shelf life, and those requiring special conditions such as refrigeration or flammable item handling must comply with relevant regulations. Only manufacturers or authorized resellers may submit quotes, which are due via email by June 26, 2026. The contract period covers 12 consecutive months from the award date, with performance based at the FDA facility in Silver Spring, Maryland. The procurement process is issued as a combined synopsis/solicitation under commercial item acquisition rules, with no separate solicitation document forthcoming. The solicitation emphasizes strict adherence to delivery schedules and quality standards detailed in the attached Statement of Work. Communication and submission of quotations are managed through the designated FDA point of contact.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 10 days
View Details